Matches in SemOpenAlex for { <https://semopenalex.org/work/W103698556> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W103698556 endingPage "12" @default.
- W103698556 startingPage "203" @default.
- W103698556 abstract "The purpose of this study was to determine the long-term follow-up on survival of patients with carcinoma of unknown primary site treated with taxane-based chemotherapy in a multicenter community-based setting.Patients were treated with three sequential phase II trials between 1995 and 1998 as follows: Study I: paclitaxel 200 mg/m2 intravenously (i.v.) Day 1, carboplatin AUC = 6 i.v. Day 1, and oral etoposide 50 mg daily alternating with 100 mg daily days 1-10 every 3 weeks; Study II: docetaxel 75 mg/m2 i.v. Day 1, cisplatin 75 mg/m2 i.v. Day 1, repeated every 3 weeks; Study III: docetaxel 65 mg/m2 i.v. Day 1, carboplatin AUC 6 i.v. Day 1, repeated every 3 weeks. A total of 144 patients (71 on Study I, 26 on Study II, 47 on Study III) were treated (45% had well differentiated carcinoma, 48% had poorly differentiated carcinomas, and 6% poorly differentiated neuroendocrine tumors). The majority of the patients had multiple sites of metastatic disease.Thirty-six percent of all evaluable patients responded to therapy (27% partial and 9% complete responses). The median survival was 10 months with 1-, 2-, 3-, and 4-year survivals of 42%, 22%, 17%, and 17%, respectively. Follow-up ranges from 11 to 50 months. Women survived significantly longer than men. Thirty-one patients remain alive and 14 are progression-free. The primary toxicity was leukopenia with the carboplatin regimens and nausea and vomiting with the cisplatin regimen. A review of the survival of several large previously reported series of patients was compared to results after taxane-based chemotherapy. A compelling argument is made that chemotherapy is superior to best supportive care alone and that taxane-based chemotherapy is superior to other forms of chemotherapy. However, prospective randomized trials will be necessary to definitively demonstrate the superiority of this treatment compared to other therapies for these patients.Taxane-based chemotherapy for patients with carcinoma of unknown primary site appears to be clinically beneficial and is associated with long-term survival for a minority of patients at 2-, 3-, and 4-year follow-up." @default.
- W103698556 created "2016-06-24" @default.
- W103698556 creator A5008331637 @default.
- W103698556 creator A5031741135 @default.
- W103698556 creator A5035473982 @default.
- W103698556 creator A5050671373 @default.
- W103698556 creator A5065917441 @default.
- W103698556 creator A5073724595 @default.
- W103698556 date "2001-06-23" @default.
- W103698556 modified "2023-09-23" @default.
- W103698556 title "Taxane-based chemotherapy for patients with carcinoma of unknown primary site." @default.
- W103698556 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11419028" @default.
- W103698556 hasPublicationYear "2001" @default.
- W103698556 type Work @default.
- W103698556 sameAs 103698556 @default.
- W103698556 citedByCount "14" @default.
- W103698556 countsByYear W1036985562012 @default.
- W103698556 crossrefType "journal-article" @default.
- W103698556 hasAuthorship W103698556A5008331637 @default.
- W103698556 hasAuthorship W103698556A5031741135 @default.
- W103698556 hasAuthorship W103698556A5035473982 @default.
- W103698556 hasAuthorship W103698556A5050671373 @default.
- W103698556 hasAuthorship W103698556A5065917441 @default.
- W103698556 hasAuthorship W103698556A5073724595 @default.
- W103698556 hasConcept C121608353 @default.
- W103698556 hasConcept C126322002 @default.
- W103698556 hasConcept C141071460 @default.
- W103698556 hasConcept C143998085 @default.
- W103698556 hasConcept C2776694085 @default.
- W103698556 hasConcept C2777511904 @default.
- W103698556 hasConcept C2778119113 @default.
- W103698556 hasConcept C2778239845 @default.
- W103698556 hasConcept C2778336483 @default.
- W103698556 hasConcept C2780580376 @default.
- W103698556 hasConcept C2780852908 @default.
- W103698556 hasConcept C2780873365 @default.
- W103698556 hasConcept C2781190966 @default.
- W103698556 hasConcept C2781413609 @default.
- W103698556 hasConcept C2781451048 @default.
- W103698556 hasConcept C31760486 @default.
- W103698556 hasConcept C530470458 @default.
- W103698556 hasConcept C71924100 @default.
- W103698556 hasConcept C90924648 @default.
- W103698556 hasConceptScore W103698556C121608353 @default.
- W103698556 hasConceptScore W103698556C126322002 @default.
- W103698556 hasConceptScore W103698556C141071460 @default.
- W103698556 hasConceptScore W103698556C143998085 @default.
- W103698556 hasConceptScore W103698556C2776694085 @default.
- W103698556 hasConceptScore W103698556C2777511904 @default.
- W103698556 hasConceptScore W103698556C2778119113 @default.
- W103698556 hasConceptScore W103698556C2778239845 @default.
- W103698556 hasConceptScore W103698556C2778336483 @default.
- W103698556 hasConceptScore W103698556C2780580376 @default.
- W103698556 hasConceptScore W103698556C2780852908 @default.
- W103698556 hasConceptScore W103698556C2780873365 @default.
- W103698556 hasConceptScore W103698556C2781190966 @default.
- W103698556 hasConceptScore W103698556C2781413609 @default.
- W103698556 hasConceptScore W103698556C2781451048 @default.
- W103698556 hasConceptScore W103698556C31760486 @default.
- W103698556 hasConceptScore W103698556C530470458 @default.
- W103698556 hasConceptScore W103698556C71924100 @default.
- W103698556 hasConceptScore W103698556C90924648 @default.
- W103698556 hasIssue "3" @default.
- W103698556 hasLocation W1036985561 @default.
- W103698556 hasOpenAccess W103698556 @default.
- W103698556 hasPrimaryLocation W1036985561 @default.
- W103698556 hasRelatedWork W103698556 @default.
- W103698556 hasRelatedWork W1847381023 @default.
- W103698556 hasRelatedWork W1975313930 @default.
- W103698556 hasRelatedWork W2102924243 @default.
- W103698556 hasRelatedWork W2185879916 @default.
- W103698556 hasRelatedWork W2244266286 @default.
- W103698556 hasRelatedWork W2252337021 @default.
- W103698556 hasRelatedWork W2252341082 @default.
- W103698556 hasRelatedWork W2325720481 @default.
- W103698556 hasRelatedWork W2397732494 @default.
- W103698556 hasVolume "7" @default.
- W103698556 isParatext "false" @default.
- W103698556 isRetracted "false" @default.
- W103698556 magId "103698556" @default.
- W103698556 workType "article" @default.